NDC 80425-0199-04 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0199
- Requested NDC
- 80425-0199-04
- Package NDCs from labels
- 80425-0199-2, 80425-0199-3, 80425-0199-1, 80425-0199-4, 80425-0199-04
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0199-1 | Gabapentin | 30 in 1 BOTTLE | CAPSULE | 30 | 5 | |
| 80425-0199-2 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 5 | |
| 80425-0199-3 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 5 | |
| 80425-0199-4 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0199 | GABAPENTIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 4 package rows | 20250101_ec1c621b-db2a-1567-e053-2995a90a8695.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0199-1 | EA - Each | 80425-0199 | d68dc437-0849-41c2-b17b-257d12f6b61c | 1 | 2023-06-06 |
| 80425-0199-2 | EA - Each | 80425-0199 | 72852c7a-f605-4712-bd72-41cd7fab8078 | 1 | 2023-06-06 |
| 80425-0199-3 | EA - Each | 80425-0199 | d088f4ae-c84a-47de-954a-d5659921b2bf | 1 | 2023-06-06 |
| 80425-0199-4 | EA - Each | 80425-0199 | 23d7cfee-4b7b-41a1-a066-247e8cdd763e | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 54c09aa5-6724-480a-a115-c88484e39e93 | 2026-02-24 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advagen Pharma Ltd | 401b30fc-e143-4906-aae1-e5b5c190d4a8 | 2026-02-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Advagen Pharma Ltd | bfee67dc-d2b1-4a00-92d9-a42be3189c74 | 2026-02-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 9814b76c-87c6-4746-b712-3269352a901b | 2026-02-16 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | d8daa30f-1cb3-46aa-9b68-d9aa5b0a2105 | 2026-02-12 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | c979f80b-d4b1-40f7-b878-b216db5f325d | 2026-02-10 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | b88b0cbc-c883-4d17-8f46-0e5bddc57835 | 2026-02-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 3dbd447f-4791-4c62-86b4-6f7928862785 | 2026-02-10 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 081fd1de-acaa-4685-a053-4959d77b17e9 | 2026-02-10 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 0e1d17d5-d39c-4144-aac0-7c0d3bc9ec0d | 2026-02-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 2343e3a1-82d0-4c70-a086-a01a0ce81ef3 | 2026-02-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 67330eef-c976-4862-b1ae-20f30f43df76 | 2026-02-09 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 2e331641-ec26-4d76-b16b-a9863c767afe | 2026-02-06 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | cc1998a7-7004-4688-8b5b-525041851d1d | 2026-02-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 4aa69d04-6b32-4764-a48b-ef5313dd95d3 | 2026-01-23 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 60b46f6d-efbc-487a-b672-b20df8b44cc4 | 2026-01-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 43a3ec78-8235-4d46-a343-2f9226745a39 | 2026-01-23 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 685553b0-384e-400b-a8ae-612ceece8261 | 2026-01-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | A-S Medication Solutions | 7ea0b220-edbb-45eb-aeb3-65283f8489a1 | 2026-01-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Preferred Pharmaceuticals, Inc. | bff3beea-1f05-4e84-bcd2-d05782acddae | 2026-01-14 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.